renzapride has been researched along with ramosetron in 2 studies
Studies (renzapride) | Trials (renzapride) | Recent Studies (post-2010) (renzapride) | Studies (ramosetron) | Trials (ramosetron) | Recent Studies (post-2010) (ramosetron) |
---|---|---|---|---|---|
70 | 12 | 2 | 194 | 94 | 83 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ito, H; Kamato, T; Miyata, K; Nagakura, Y; Nishida, A; Yamano, M | 1 |
Kamato, T; Miyata, K; Nagakura, Y; Naitoh, Y; Yamano, M | 1 |
2 other study(ies) available for renzapride and ramosetron
Article | Year |
---|---|
Characterization of 5-hydroxytryptamine (5-HT) receptor subtypes influencing colonic motility in conscious dogs.
Topics: 4-Aminobenzoic Acid; Animals; Benzamides; Benzimidazoles; Biguanides; Bridged Bicyclo Compounds, Heterocyclic; Colon; Dogs; Dose-Response Relationship, Drug; Gastrointestinal Motility; Hexamethonium; Injections, Intravenous; Ketanserin; Male; Methysergide; Muscle Contraction; Muscle, Smooth; para-Aminobenzoates; Receptors, Serotonin; Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists; Structure-Activity Relationship; Transducers | 1996 |
Compounds possessing 5-HT3 receptor antagonistic activity inhibit intestinal propulsion in mice.
Topics: Adrenergic alpha-Agonists; Animals; Benzamides; Benzimidazoles; Bridged Bicyclo Compounds, Heterocyclic; Cholinesterase Inhibitors; Cisapride; Clonidine; Gastrointestinal Transit; Intestines; Male; Mice; Mice, Inbred C57BL; Neostigmine; Ondansetron; Piperidines; Receptors, Serotonin; Serotonin Antagonists | 1996 |